Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?

被引：10
作者：
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ,2 ]
Oikonomou, Evangelos [1 ]
Stougianos, Pavlos [2 ]
Papageorgiou, Nikolaos [1 ]
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Dept 1, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 153卷 / 02期
关键词：
Asymmetric dimethylarginine; Biomarker; Cardiovascular disease; Atherosclerosis; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; L-ARGININE; PLASMA-LEVELS; RISK; EVENTS; MORTALITY; MARKER; DEATH;
D O I：
10.1016/j.ijcard.2011.08.070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 25 条
[1]   Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk [J].
Boeger, Rainer H. ;
Maas, Renke ;
Schulze, Friedrich ;
Schwedhelm, Edzard .
PHARMACOLOGICAL RESEARCH, 2009, 60 (06) :481-487
[2]   Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community [J].
Boeger, Rainer H. ;
Sullivan, Lisa M. ;
Schwedhelm, Edzard ;
Wang, Thomas J. ;
Maas, Renke ;
Benjamin, Emelia J. ;
Schulze, Friedrich ;
Xanthakis, Vanessa ;
Benndorf, Ralf A. ;
Vasan, Ramachandran S. .
CIRCULATION, 2009, 119 (12) :1592-U65
[3]   Asymmetric dimethylarginine (ADMA):: A novel risk marker in cardiovascular medicine and beyond [J].
Böger, RH .
ANNALS OF MEDICINE, 2006, 38 (02) :126-136
[4]   Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Szuba, A ;
Tsao, PS ;
Chan, JR ;
Tangphao, O ;
Blaschke, TF ;
Cooke, JP .
CIRCULATION, 1998, 98 (18) :1842-1847
[5]   Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease [J].
Boger, RH ;
BodeBoger, SM ;
Thiele, W ;
Junker, W ;
Alexander, K ;
Frolich, JC .
CIRCULATION, 1997, 95 (08) :2068-2074
[6]   LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases [J].
Böger, RH ;
Sydow, K ;
Borlak, J ;
Thum, T ;
Lenzen, H ;
Schubert, B ;
Tsikas, D ;
Bode-Böger, SM .
CIRCULATION RESEARCH, 2000, 87 (02) :99-105
[7]   Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure [J].
Dueckelmann, Christina ;
Mittermayer, Friedrich ;
Haider, Dominik Georg ;
Altenberger, Johann ;
Eichinger, Joerg ;
Wolzt, Michael .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (09) :2037-2042
[8]   Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension [J].
Gorenflo, M ;
Zheng, CB ;
Werle, E ;
Fiehn, W ;
Ulmer, HE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (04) :489-492
[9]  
Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594
[10]   Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women - 24-year follow-up of the population study of women in Gothenburg [J].
Leong, Tora ;
Zylberstein, Dimitri ;
Graham, Ian ;
Lissner, Lauren ;
Ward, Deirdre ;
Fogarty, Jane ;
Bengtsson, Calle ;
Bjoerkelund, Cecilia ;
Thelle, Dag .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) :961-967
123